Market Sector | Growth |
---|---|
Vaccine technology | Next-generation vaccines such as nanoparticles (including virus-like particles), mRNA, synthetic, and recombinant vaccines |
Virtual care | COVID-19; Rise in home-based diagnostics; digital, wearable, connected devices |
Artificial intelligence (AI)-based medical imaging | Rising volumes of patient imaging, acute shortage of radiologists required to review them |
Hospital efficiency solutions | Increased aging population and patients with chronic conditions; Shortage of healthcare personnel; push for value-based care |
Digital biomarkers | Improve personalized treatment, preventive measures; Biopharma precision drug development; Provides reactive, preventive approach to healthcare |
Microbiome therapeutics | Three potential therapies undergoing pivotal clinical studies and likely to garner U.S. FDA nods in 2021; no approvals yet |
Combination immuno-oncology (I-O) therapies | Rising cancer cases and increasing R&D investments; Demonstrated effectiveness of combination therapy |
Laboratory information management solutions (LIMS) | Data migration from legacy infrastructures to the cloud; increasingly complex data management, storage, analytics |
Explore the April 2021 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Best of 2024: #10 Article – Designing medical devices for every user
- Best of 2024: #10 News – 4 predictions for 2024: AI set to supercharge robotic automation
- Children’s National, FDA collaborate to advance pediatric device regulatory tools
- LK Metrology’s eco-friendliness CMMs
- Two patents for microfluidic valves
- AMADA WELD TECH’s blue diode laser technology
- Post-IMTS decline in manufacturing technology orders blunted
- ARS Automation’s FlexiBowl 200